62/100B416.68
USD
0.61
(0.15%)
Market Closed
Last updated: · Delayed 15 min
BeiGene net income 2013–2026What is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
BeiGene earned 384.71M USD in Q3 FY2026, the three months to 30 September 2026, up 208.2% on the same quarter a year before. BeiGene's net income over the last twelve months was 915.57M USD, up 1,235.6% on the twelve months before. In fiscal year 2025 it earned 286.93M USD, against a loss of 644.79M USD on the year before.
Last updated 12 Nov 2026 · Next report 25 Feb 2027
Net income
Net income Net margin
| Fiscal year | Period ending | Net income | Growth | Net margin | Revenue |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 915.57M | +1,235.63% | 13.86% | 6.61B |
| FY2025 | 31 Dec 2025 | 286.93M | — | 5.37% | 5.34B |
| FY2024 | 31 Dec 2024 | -644.79M | — | -16.92% | 3.81B |
| FY2023 | 31 Dec 2023 | -881.71M | — | -35.86% | 2.46B |
| FY2022 | 31 Dec 2022 | -2.00B | — | -141.52% | 1.42B |
| FY2021 | 31 Dec 2021 | -1.46B | — | -123.93% | 1.18B |
| FY2020 | 31 Dec 2020 | -1.62B | — | -526.10% | 308.87M |
| FY2019 | 31 Dec 2019 | -948.63M | — | -221.53% | 428.21M |
| FY2018 | 31 Dec 2018 | -673.77M | — | -339.91% | 198.22M |
| FY2017 | 31 Dec 2017 | -93.11M | — | -39.06% | 238.39M |
| FY2016 | 31 Dec 2016 | -119.22M | — | -11,141.78% | 1.07M |
| FY2015 | 31 Dec 2015 | -57.10M | — | -647.71% | 8.82M |
| FY2014 | 31 Dec 2014 | -18.28M | — | -140.22% | 13.04M |
| FY2013 | 31 Dec 2013 | -7.49M | — | -67.22% | 11.15M |
| Quarter | Period ending | Net income | Growth on a year before | Net margin | Revenue |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 384.71M | +208.16% | 20.36% | 1.89B |
| Q2 FY2026 | 30 Jun 2026 | 237.01M | +151.28% | 13.90% | 1.71B |
| Q1 FY2026 | 31 Mar 2026 | 227.36M | +17,802.13% | 15.02% | 1.51B |
| Q4 FY2025 | 31 Dec 2025 | 66.50M | — | 4.44% | 1.50B |
| Q3 FY2025 | 30 Sept 2025 | 124.84M | — | 8.84% | 1.41B |
| Q2 FY2025 | 30 Jun 2025 | 94.32M | — | 7.17% | 1.32B |
| Q1 FY2025 | 31 Mar 2025 | 1.27M | — | 0.11% | 1.12B |
| Q4 FY2024 | 31 Dec 2024 | -151.88M | — | -13.47% | 1.13B |
| Q3 FY2024 | 30 Sept 2024 | -121.35M | -156.33% | -12.12% | 1.00B |
| Q2 FY2024 | 30 Jun 2024 | -120.41M | — | -12.96% | 929.17M |
| Q1 FY2024 | 31 Mar 2024 | -251.15M | — | -33.41% | 751.65M |
| Q4 FY2023 | 31 Dec 2023 | -367.55M | — | -57.94% | 634.41M |
| Q3 FY2023 | 30 Sept 2023 | 215.41M | — | 27.57% | 781.31M |
| Q2 FY2023 | 30 Jun 2023 | -381.14M | — | -64.03% | 595.26M |
| Q1 FY2023 | 31 Mar 2023 | -348.43M | — | -77.81% | 447.80M |
| Q4 FY2022 | 31 Dec 2022 | -445.34M | — | -117.16% | 380.10M |
| Q3 FY2022 | 30 Sept 2022 | -557.56M | — | -143.84% | 387.63M |
| Q2 FY2022 | 30 Jun 2022 | -565.73M | — | -165.62% | 341.57M |
| Q1 FY2022 | 31 Mar 2022 | -435.20M | -754.48% | -141.93% | 306.63M |
| Q4 FY2021 | 31 Dec 2021 | -585.65M | — | -273.70% | 213.98M |
| Q3 FY2021 | 30 Sept 2021 | -438.11M | — | -212.22% | 206.44M |
| Q2 FY2021 | 30 Jun 2021 | -480.34M | — | -320.24% | 149.99M |
| Q1 FY2021 | 31 Mar 2021 | 66.50M | — | 10.98% | 605.87M |
| Q4 FY2020 | 31 Dec 2020 | -472.75M | — | -472.27% | 100.10M |
| Q3 FY2020 | 30 Sept 2020 | -425.22M | — | -466.87% | 91.08M |
| Q2 FY2020 | 30 Jun 2020 | -335.20M | — | -510.71% | 65.64M |
| Q1 FY2020 | 31 Mar 2020 | -363.74M | — | -698.70% | 52.06M |
| Q4 FY2019 | 31 Dec 2019 | -388.06M | — | -682.10% | 56.89M |
| Q3 FY2019 | 30 Sept 2019 | -307.36M | — | -612.99% | 50.14M |
| Q2 FY2019 | 30 Jun 2019 | -85.57M | — | -35.16% | 243.35M |
| Q1 FY2019 | 31 Mar 2019 | -167.64M | — | -215.38% | 77.83M |
| Q4 FY2018 | 31 Dec 2018 | -268.26M | — | -457.23% | 58.67M |
| Q3 FY2018 | 30 Sept 2018 | -144.03M | -222.70% | -265.73% | 54.20M |
| Q2 FY2018 | 30 Jun 2018 | -156.89M | — | -297.11% | 52.80M |
| Q1 FY2018 | 31 Mar 2018 | -104.60M | — | -321.40% | 32.54M |
| Q4 FY2017 | 31 Dec 2017 | -99.32M | — | -546.51% | 18.17M |
| Q3 FY2017 | 30 Sept 2017 | 117.39M | — | 53.31% | 220.21M |
| Q2 FY2017 | 30 Jun 2017 | -60.55M | — | — | 0.00 |
| Q1 FY2017 | 31 Mar 2017 | -50.62M | — | — | 0.00 |
| Q4 FY2016 | 31 Dec 2016 | -37.60M | — | — | 0.00 |
| Q3 FY2016 | 30 Sept 2016 | -35.49M | — | — | 0.00 |
| Q2 FY2016 | 30 Jun 2016 | -24.12M | — | -6,138.42% | 393.00K |
| Q1 FY2016 | 31 Mar 2016 | -22.00M | — | -3,249.78% | 677.00K |
| Q4 FY2015 | 31 Dec 2015 | -27.25M | — | -582.64% | 4.68M |
| Q3 FY2015 | 30 Sept 2015 | -14.00M | — | -1,014.42% | 1.38M |
| Q2 FY2015 | 30 Jun 2015 | -5.64M | — | -408.77% | 1.38M |
| Q1 FY2015 | 31 Mar 2015 | -10.21M | — | -740.54% | 1.38M |
| Q4 FY2014 | 31 Dec 2014 | -3.75M | — | -271.61% | 1.38M |
| Q3 FY2014 | 30 Sept 2014 | -9.76M | — | -150.23% | 6.50M |
| Q2 FY2014 | 30 Jun 2014 | -2.38M | — | -92.44% | 2.58M |
| Q1 FY2014 | 31 Mar 2014 | -2.38M | — | -92.44% | 2.58M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement
Common questions about BeiGene's profit
Source: Financial Modeling Prep